Evidence map›Paper›PMID 36808719›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023

Phosphomevalonate Kinase Controls β-Catenin Signaling via the Metabolite 5-Diphosphomevalonate.

Zhiqiang Chen, Xinyi Zhou, Xiaojun Zhou, Yi Tang, Mingzhu Lu, Jianhong Zhao, Chenhui Tian, Mingzhi Wu, Yanliang Liu, Edward V Prochownik and 2 more

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. BoltzGen: Toward Universal Binder Design.bioRxiv : the preprint server for biology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Increases in 4-Acetaminobutyric Acid Generated by Phosphomevalonate Kinase Suppress CD8Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Zhiqiang ChenHubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Frontier Science Center for Immunology and Metabolism, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, 430072, P. R. China.
Xinyi ZhouHubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Frontier Science Center for Immunology and Metabolism, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, 430072, P. R. China.
Xiaojun ZhouHubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Frontier Science Center for Immunology and Metabolism, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, 430072, P. R. China.
Yi TangHubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Frontier Science Center for Immunology and Metabolism, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, 430072, P. R. China.
Mingzhu LuHubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Frontier Science Center for Immunology and Metabolism, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, 430072, P. R. China.
Jianhong ZhaoHubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Frontier Science Center for Immunology and Metabolism, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, 430072, P. R. China.
Chenhui TianHubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Frontier Science Center for Immunology and Metabolism, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, 430072, P. R. China.
Mingzhi WuHubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Frontier Science Center for Immunology and Metabolism, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, 430072, P. R. China.
Yanliang LiuDepartment of Gastrointestinal Surgery, Renmin Hospital of Wuhan University, Wuhan, 430060, P. R. China.
Edward V ProchownikDivision of Hematology/Oncology, Children's Hospital of Pittsburgh of UPMC, Department of Microbiology and Molecular Genetics, Pittsburgh Liver Research Center and Hillman Cancer Center of UPMC, University of Pittsburgh Medical Center, Pittsburgh, PA, 15224, USA.
Fubing WangDepartment of Laboratory Medicine and Center for Single-Cell Omics and Tumor Liquid Biopsy, Zhongnan Hospital of Wuhan University, Wuhan, 430071, P. R. China.
Youjun LiHubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Frontier Science Center for Immunology and Metabolism, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, 430072, P. R. China.ORCID 0000-0003-0133-1277
Wuhan University · CNUPMC Hillman Cancer Center · US

Funding

Fundamental Research Funds for the Central Universities 2042021kf0229Medical Science Advancement Program (Basic Medical Sciences) of Wuhan University TFJC2018005National Nature Science Foundation of China 32270828National Nature Science Foundation of China 81772609National Nature Science Foundation of China 92057108Sino-foreign Joint Scientific Research Platform Seed Fund of Wuhan University WHUZZJJ202204
6 · The paper itself

Abstract

β-catenin signaling is abnormally activated in cancer. Here, this work screens the mevalonate metabolic pathway enzyme PMVK to stabilize β-catenin signaling using a human genome-wide library. On the one hand, PMVK-produced MVA-5PP competitively binds to CKIα to prevent β-catenin Ser45 phosphorylation and degradation. On the other hand, PMVK functions as a protein kinase to directly phosphorylate β-catenin Ser184 to increase its protein nuclear localization. This synergistic effect of PMVK and MVA-5PP together promotes β-catenin signaling. In addition, PMVK deletion impairs mouse embryonic development and causes embryonic lethal. PMVK deficiency in liver tissue alleviates DEN/CCl

Indexed as

beta CateninMevalonic AcidAnimalsEmbryonic DevelopmentHumansMicePhosphotransferases (Phosphate Group Acceptor)Signal Transductionbeta CateninMevalonic Acidphosphomevalonate kinasePhosphotransferases (Phosphate Group Acceptor)casein kinase Iαhepatocellular carcinomamevalonate 5-diphosphatephosphomevalonate kinaseβ-catenin

Identifiers

PMID36808719
PMCPMC10131864
OpenAlexW4321443834

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.